Abstract:Cancer is one of the most serious issues in human life. Blocking programmed cell death protein 1 and programmed death ligand-1 (PD-L1) pathway is one of the great innovations in the last few years, a few numbers of inhibitors can be able to block it. (2-Methyl-3-biphenylyl) methanol derivative is one of them. Here, the quantitative structure-activity relationship (QSAR) established twenty (2-methyl-3-biphenylyl) methanol derivatives as the programmed death ligand-1 inhibitors. Density functional theory at the B3LPY/6-31+G(d,p) level was employed to study the chemical structure and properties of the chosen compounds. Highest occupied molecular orbital energy EHOMO, lowest unoccupied molecular orbital energy ELUMO, total energy ET, dipole moment DM, absolute hardness η, absolute electronegativity χ, softness S, electrophilicity ω, energy gap ΔE, etc., were observed and determined. Principal component analysis (PCA), multiple linear regression (MLR) and multiple non-linear regression (MNLR) analysis were carried out to establish the QSAR. The proposed quantitative models and interpreted outcomes of the compounds were based on statistical analysis. Statistical results of MLR and MNLR exhibited the coefficient R2 was 0.661 and 0.758, respectively. Leave-one-out cross-validation, <math>rm2</math> metric, <math>rm2</math> test, and "Golbraikh & Tropsha's criteria" analyses were applied for the validation of MLR and MNLR, which indicate two models are statistically significant and well stable with data variation in the external validation towards PD-L1. The obtained results showed that the MNLR model predicts the bioactivity more accurately than MLR, and it may be helpful and supporting for evaluation of the biological activity of PD-L1 inhibitors.

QSAR study of flavonoids inhibitors of the PIM-1 kinase

3D-QSAR study on the inhibitory activity of flavonoids on PIM-1 kinase

QSAR Research of Novel Tetrandrine Derivatives Against Human Hepatocellular Carcinoma.

QSAR study of fiavonoids derivatives as p56lck protein tyrosine kinase inhibitors using GA-SVM

Pharmacophore modeling and 3D-QSAR analysis of phosphoinositide 3-kinase p110alpha inhibitors.

Molecular insights and inhibitory dynamics of flavonoids in targeting Pim-1 kinase for cancer therapy

In silico design and ADMET evaluation of new inhibitors for PIM1 kinase using QSAR studies, molecular docking, and molecular dynamic simulation

Pharmacophore modeling and 3D-QSAR analysis of phosphoinositide 3-kinase p110α inhibitors

3D-QSAR Study on 2,3-Dihydroimidazo[4,5]-pyridin-2-one Derivatives with a Meta Substitution Pattern As V600E BRAF Inhibitors

3D-QSAR Study for Inhibitors of Cyclin-Dependent Kinase 4

3D-QSAR and Docking Study on 3-Benzimidazol-2-ylhydroquinolin-2-one Derivatives As VEGFR-2 Tyrosine Kinase Inhibitors

3D-QSAR studies of flavones

An in Silico Approach for Screening Flavonoids As P-glycoprotein Inhibitors Based on a Bayesian-regularized Neural Network

QSAR study of tetrahydropteridin derivatives as polo-like kinase 1(PLK1) Inhibitors with molecular docking and dynamics study

Theoretical investigation on QSAR of (2-Methyl-3-biphenylyl) methanol analogs as PD-L1 inhibitor

A QSAR study of 1,2-diarylimidazole cyclooxygenase-2 inhibitors

QSAR Studies of Imidazopyridine Derivatives As Et-PKG Inhibitors Using the PSO-SVM Approach

Toward the Identification of a Reliable 3D-QSAR Model for the Protein Tyrosine Phosphatase 1B Inhibitors

QSAR models for isoindolinone-based p53-MDM2 interaction inhibitors using linear and non-linear statistical methods.

Pharmacophore Modeling, Atom-Based 3D-QSAR and Molecular Docking Studies on N -Benzylpyrimidin-4-amine Derivatives As VCP/p97 Inhibitors

QSAR and molecular docking studies on oxindole derivatives as VEGFR-2 tyrosine kinase inhibitors